NAIROBI — 13 November 2026. Applications remain open for Villgro Africa’s MedTech Innovation Programme, with a published deadline of 16 November 2026. The call targets locally led medical-technology businesses in six East African countries and offers a route from working prototypes towards safer, more commercially viable products.
The immediate task for founders is to check whether their technology fits, prepare the supporting evidence and use the programme-specific application route. Participation should not be confused with an automatic cash award.
Who can apply for Villgro’s MedTech programme?
Locally led medical-device companies in Kenya, Uganda, Tanzania, Rwanda, Burundi and Ethiopia can apply with a functional proof of concept or prototype. Six enterprises will receive tailored support over 24 months. The published deadline is 16 November 2026; a closing hour is not specified.
Check the hardware requirement first
The programme description on VC4A focuses on medical hardware. A locally developed diagnostic device, patient monitor or maternal-health instrument can fit; a generic wellness app, clinic administration tool or distribution-only business is outside the main scope unless a distinctive medical or manufacturing technology is central.
Applicants need technical and business leadership, user engagement and clear ownership of the technology. Companies still registering may apply, but must complete incorporation before onboarding.
For a founder, the useful first question is therefore specific: what physical product has the team built, what health need does it address, and what evidence shows that it works? A persuasive description of a problem is different from evidence about a prototype.
Disrupt Africa’s report identifies product validation, regulatory readiness, manufacturing, market development and investment readiness among the support areas. Those are steps in developing a business and its product, rather than a declaration that a device is approved for clinical use.
Prepare one consistent application package
TECH AND STARTUPS
Villgro MedTech Application Guide: Deadline and Eligibility
Nov 13, 2026
Nov 13, 2026
6 min read
Published
Updated:
NAIROBI — 13 November 2026. Applications remain open for Villgro Africa’s MedTech Innovation Programme, with a published deadline of 16 November 2026. The call targets locally led medical-technology businesses in six East African countries and offers a route from working prototypes towards safer, more commercially viable products.
The immediate task for founders is to check whether their technology fits, prepare the supporting evidence and use the programme-specific application route. Participation should not be confused with an automatic cash award.
Who can apply for Villgro’s MedTech programme?
Locally led medical-device companies in Kenya, Uganda, Tanzania, Rwanda, Burundi and Ethiopia can apply with a functional proof of concept or prototype. Six enterprises will receive tailored support over 24 months. The published deadline is 16 November 2026; a closing hour is not specified.
Check the hardware requirement first
The programme description on VC4A focuses on medical hardware. A locally developed diagnostic device, patient monitor or maternal-health instrument can fit; a generic wellness app, clinic administration tool or distribution-only business is outside the main scope unless a distinctive medical or manufacturing technology is central.
ADVERTISEMENT
Applicants need technical and business leadership, user engagement and clear ownership of the technology. Companies still registering may apply, but must complete incorporation before onboarding.
For a founder, the useful first question is therefore specific: what physical product has the team built, what health need does it address, and what evidence shows that it works? A persuasive description of a problem is different from evidence about a prototype.
Disrupt Africa’s report identifies product validation, regulatory readiness, manufacturing, market development and investment readiness among the support areas. Those are steps in developing a business and its product, rather than a declaration that a device is approved for clinical use.
Prepare one consistent application package
The call requests a pitch deck of no more than 15 slides, a product brief, testing or pilot evidence, regulatory and intellectual-property information, company and ownership details, financial records and funding needs. A demonstration video is recommended.
Arrange the material so that the documents describe the same product and stage of development. If the deck describes a prototype, the financial plan should not present full-scale manufacturing as an accomplished fact. Distinguish work already completed from the milestones that support would help the company reach.
ADVERTISEMENT
Popular Today
A useful preparation sequence is:
Describe the intended user and the problem the device addresses.
Summarise what has actually been built and tested.
Identify the remaining technical, regulatory and manufacturing work.
Explain who would buy, maintain or pay for the product.
Make the requested support match those remaining tasks.
This is a way to organise the evidence, not a promise about how an individual application will be scored. Unsupported claims about accuracy, patient outcomes or commercial traction will not become stronger because they appear in several documents.
Use the programme-specific VC4A route
The application entry page requires applicants to sign in. New users can create a VC4A account, return to the programme and begin their application.
VC4A’s guidance says applicants should complete required fields, accept the relevant terms and submit. It also says a confirmation email follows submission. Saving work and submitting it are different stages: retain the confirmation rather than assuming a partly completed form has entered the selection process.
Where a venture profile is used to prefill information, review it before proceeding. Old staffing, funding or product details can create inconsistencies with the current application. Use the same account when returning to saved work; VC4A identifies multiple accounts as one reason applicants struggle to locate an application.
ADVERTISEMENT
Do not import funding promises from another offer
Villgro’s general incubation and funding page describes mentorship, technical assistance, market connections and seed-capital opportunities across its wider work. Those general portfolio offers should not be substituted for this cohort’s specific terms.
The MedTech call sets out a technical-support programme, but does not publish a guaranteed cash amount for every selected enterprise. Before accepting an offer, ask what support is included, whether any financial contribution or equity arrangement applies, and what participation commitments are expected. Investment readiness and introductions to funders do not mean an investment has been secured.
Submit ahead of the date, then retain the record
The deadline date is clear; its precise closing hour is not. Submit ahead of 16 November rather than assuming midnight in your own country. Direct programme questions to medtech@villgroafrica.org, the contact listed with the call.
Keep copies of submitted documents and the confirmation email. The next stages include screening, review, interviews or demonstrations and due diligence before an offer. An application is an entry into that process, not confirmation of selection, product approval or future sales.
ADVERTISEMENT
Related Articles
